Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes
- PMID: 22101218
- PMCID: PMC3268833
- DOI: 10.1016/j.cct.2011.11.002
Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes
Abstract
Background: HIV-infected prisoners experience poor HIV treatment outcomes post-release. Directly administered antiretroviral therapy (DAART) is a CDC-designated, evidence-based adherence intervention for drug users, yet untested among released prisoners.
Methods: Sentenced HIV-infected prisoners on antiretroviral therapy (ART) and returning to New Haven or Hartford, Connecticut were recruited and randomized 2:1 to a prospective controlled trial (RCT) of 6 months of DAART versus self-administered therapy (SAT); all subjects received case management services. Subjects meeting DSM-IV criteria for opioid dependence were offered immediate medication-assisted treatment. Trained outreach workers provided DAART once-daily, seven days per week, including behavioral skills training during the last intervention month. Both study groups were assessed for 6 months after the intervention period. Assessments occurred within 90 days pre-release (baseline), day of release, and then monthly for 12 months. Viral load (VL) and CD4 testing was conducted baseline and quarterly; genotypic resistance testing was conducted at baseline, 6 and 12 months. The primary outcome was pre-defined as viral suppression (VL<400 copies/mL) at 6 months.
Results: Between 2004 and 2009, 279 participants were screened, of which 202 met eligibility criteria and 154 were ultimately enrolled in the study; 103 subjects were randomized to DAART and 51 to SAT. Subjects were mostly male (81.2%), people of color (87.0%), had an alcohol use disorder (39.7%), had underlying depression (54.2%), were virally suppressed (78.8%) and had a mean CD4=390.7 cells/mL.
Conclusions: Outcomes from this RCT will contribute greatly to HIV treatment outcomes after release from prison, a period associated with adverse HIV and other medical consequences.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.Clin Infect Dis. 2007 Sep 15;45(6):770-8. doi: 10.1086/521166. Epub 2007 Aug 13. Clin Infect Dis. 2007. PMID: 17712763 Free PMC article. Clinical Trial.
-
Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial.PLoS One. 2013 Jul 16;8(7):e68286. doi: 10.1371/journal.pone.0068286. Print 2013. PLoS One. 2013. PMID: 23874575 Free PMC article. Clinical Trial.
-
Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.AIDS Behav. 2015 Jan;19(1):128-36. doi: 10.1007/s10461-014-0850-8. AIDS Behav. 2015. PMID: 25055766 Free PMC article. Clinical Trial.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?AIDS Patient Care STDS. 2002 Nov;16(11):527-35. doi: 10.1089/108729102761041083. AIDS Patient Care STDS. 2002. PMID: 12513901 Review.
Cited by
-
Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.JAMA Intern Med. 2014 May;174(5):721-9. doi: 10.1001/jamainternmed.2014.601. JAMA Intern Med. 2014. PMID: 24687044 Free PMC article.
-
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.J Acquir Immune Defic Syndr. 2018 May 1;78(1):43-53. doi: 10.1097/QAI.0000000000001634. J Acquir Immune Defic Syndr. 2018. PMID: 29373393 Free PMC article. Clinical Trial.
-
Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions.AIDS Behav. 2017 Dec;21(12):3527-3548. doi: 10.1007/s10461-017-1778-6. AIDS Behav. 2017. PMID: 28534199 Free PMC article.
-
HIV treatment and care among Italian inmates: a one-month point survey.BMC Infect Dis. 2015 Dec 10;15:562. doi: 10.1186/s12879-015-1301-5. BMC Infect Dis. 2015. PMID: 26653247 Free PMC article.
-
The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs.Curr Opin HIV AIDS. 2012 Nov;7(6):563-8. doi: 10.1097/COH.0b013e328358e49e. Curr Opin HIV AIDS. 2012. PMID: 23076122 Free PMC article. Review.
References
-
- Glaze LE. Bureau of Justice Statistics. U.S. Department of Justice; Washington, D.C.: 2010. Correctional Populations in the United States, 2009.
-
- Maruschak LM. Bureau of Justice Statistics. U.S. Department of Justice; Washington: 2009. HIV in Prisons, 2007-08.
-
- Satcher Johnson A, Hu X, Hughes D, Campsmith M, Hall I, Prejean J, et al. The HIV/AIDS Surveillance Report. The HIV/AIDS Surveillance Report. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services; Atlanta: 2007.
-
- Mumola C. Substance abuse and treatment of state and federal prisoners, 1997. Bureau of Justice Statistics, US Department of Justice, Office of Justice Programs; Washington, DC: 1999.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous